Best deals to access real time data! |
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ and Amex.
Monthly Subscription
for only
|
|
VAT not included
|
|
After Hours Last Trade |
Last: $ 33.05 ▲ 0.05 (0.15%) | |
| Company Name | Stock Ticker Symbol | Market | Type | ISIN | Company Description |
|---|---|---|---|---|---|
| Pfizer, Inc. | PFE | NYSE | Ordinary Share | US7170811035 |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| +0.11 | +0.33% | 33 | 33 | 32.69 | 32.79 | 32.89 | 19:18:30 |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 62,888 | 16,661,472 | $ 32.8987 | $ 548.14M | 16.62M | 29.83 - 37.39 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:40:12 | formt | 1,000 | $33.05 | USD |
| Industry Sector |
|---|
| Drug Manufacturers - Major |
Pfizer, Inc. Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| US$ 196.94B | 5.97B | US$ 7.22B | 1.18 | 28.40 | 5.95B |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 44.38M | US$ 1.28 | 3.88% | 08/02/2017 | - | 69.60% |
Pfizer, Inc. News
United Therapeutics in Settlement Talks With Justice Department -- Update Dow Jones News • Thu Jul 27, 2017 2:27 PM (6 hours ago)
AstraZeneca Shares Dive After Major Setback Over Cancer Drugs -- 3rd Update Dow Jones News • Thu Jul 27, 2017 10:05 AM (11 hours ago)
AstraZeneca Faces Major Setback Over Cancer Drugs Dow Jones News • Thu Jul 27, 2017 3:55 AM (17 hours ago)
ViiV Healthcare Announces Superior Efficacy of Dolutegravir Versus Lopinavir/Ritonavir in Second-line HIV Treatment in Resour... PR Newswire (US) • Tue Jul 25, 2017 9:03 AM (2 days ago)
ViiV Healthcare Announces Superior Efficacy of Dolutegravir Versus Lopinavir/Ritonavir in Second-line HIV Treatment in Resour... PR Newswire (US) • Tue Jul 25, 2017 9:03 AM (2 days ago)
Samsung Enters U.S. Drug Market -- WSJ Dow Jones News • Tue Jul 25, 2017 3:02 AM (3 days ago)
Pfizer Announces Positive Top-Line Results from the Comparative REFLECTIONS B7391003 Study for PF-06439535, a Potential Biosi... Business Wire • Mon Jul 24, 2017 8:30 AM (4 days ago)
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PFE Price Data
| Period † | Open | High | Low | VWAP | Min Vol | Max Vol | Avg. Daily Vol [m] | Change | % |
|---|---|---|---|---|---|---|---|---|---|
| 1 Week | 33.47 | 33.7 | 32.69 | 33.2464 | 12M | 19M | 15M | -0.47 | -1.40% |
| 1 Month | 33.8 | 33.97 | 32.69 | 33.3674 | 9M | 19M | 14M | -0.8 | -2.37% |
| 3 Months | 33.44 | 34.48 | 31.67 | 32.9583 | 9M | 39M | 19M | -0.44 | -1.32% |
| 6 Months | 31.4 | 34.75 | 30.9343 | 33.2900 | 9M | 42M | 20M | 1.6 | 5.10% |
| 1 Year | 36.88 | 37.39 | 29.83 | 33.1116 | 9M | 113M | 21M | -3.88 | -10.52% |
| 3 Years | 29.26 | 37.39 | 27.51 | 32.4674 | 1k | 280M | 25M | 3.74 | 12.78% |
| 5 Years | 23.81 | 37.39 | 23.55 | 30.6408 | 1k | 280M | 28M | 9.19 | 38.60% |
